| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699835 | Clinical Oncology | 2007 | 5 Pages |
Abstract
This audit gives a detailed view on rising trends in transfusion requirements and, in light of anticipated restrictions on resources, it identifies high-risk areas, where the use of alternatives, such as erythropoietin, could be considered.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
U. Dernedde, R. Dernedde, L. Shepstone, A. Barrett,